Cargando…

Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility

In recent years there has been increasing interest in the pulmonary delivery of high dose dry powder drugs, such as antibiotics. Drugs in this class need to be dosed in doses far over 2.5 mg, and the use of excipients should therefore be minimized. To our knowledge, the effect of the automatic filli...

Descripción completa

Detalles Bibliográficos
Autores principales: Sibum, Imco, Hagedoorn, Paul, Botterman, Carel O., Frijlink, Henderik W., Grasmeijer, Floris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407802/
https://www.ncbi.nlm.nih.gov/pubmed/32659899
http://dx.doi.org/10.3390/pharmaceutics12070645
_version_ 1783567688322252800
author Sibum, Imco
Hagedoorn, Paul
Botterman, Carel O.
Frijlink, Henderik W.
Grasmeijer, Floris
author_facet Sibum, Imco
Hagedoorn, Paul
Botterman, Carel O.
Frijlink, Henderik W.
Grasmeijer, Floris
author_sort Sibum, Imco
collection PubMed
description In recent years there has been increasing interest in the pulmonary delivery of high dose dry powder drugs, such as antibiotics. Drugs in this class need to be dosed in doses far over 2.5 mg, and the use of excipients should therefore be minimized. To our knowledge, the effect of the automatic filling of high dose drug formulations on the maximum dose that can be filled in powder inhalers, and on the dispersion behavior of the powder, have not been described so far. In this study, we aimed to investigate these effects after filling with an Omnidose, a vacuum drum filler. Furthermore, the precision and accuracy of the filling process were investigated. Two formulations were used—an isoniazid formulation we reported previously and an amikacin formulation. Both formulations could be precisely and accurately dosed in a vacuum pressure range of 200 to 600 mbar. No change in dispersion was seen after automatic filling. Retention was decreased, with an optimum vacuum pressure range found from 400 to 600 mbar. The nominal dose for amikacin was 57 mg, which resulted in a fine particle dose of 47.26 ± 1.72 mg. The nominal dose for isoniazid could be increased to 150 mg, resulting in a fine particle dose of 107.35 ± 13.52 mg. These findings may contribute to the understanding of the upscaling of high dose dry powder inhalation products.
format Online
Article
Text
id pubmed-7407802
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74078022020-08-12 Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility Sibum, Imco Hagedoorn, Paul Botterman, Carel O. Frijlink, Henderik W. Grasmeijer, Floris Pharmaceutics Article In recent years there has been increasing interest in the pulmonary delivery of high dose dry powder drugs, such as antibiotics. Drugs in this class need to be dosed in doses far over 2.5 mg, and the use of excipients should therefore be minimized. To our knowledge, the effect of the automatic filling of high dose drug formulations on the maximum dose that can be filled in powder inhalers, and on the dispersion behavior of the powder, have not been described so far. In this study, we aimed to investigate these effects after filling with an Omnidose, a vacuum drum filler. Furthermore, the precision and accuracy of the filling process were investigated. Two formulations were used—an isoniazid formulation we reported previously and an amikacin formulation. Both formulations could be precisely and accurately dosed in a vacuum pressure range of 200 to 600 mbar. No change in dispersion was seen after automatic filling. Retention was decreased, with an optimum vacuum pressure range found from 400 to 600 mbar. The nominal dose for amikacin was 57 mg, which resulted in a fine particle dose of 47.26 ± 1.72 mg. The nominal dose for isoniazid could be increased to 150 mg, resulting in a fine particle dose of 107.35 ± 13.52 mg. These findings may contribute to the understanding of the upscaling of high dose dry powder inhalation products. MDPI 2020-07-09 /pmc/articles/PMC7407802/ /pubmed/32659899 http://dx.doi.org/10.3390/pharmaceutics12070645 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sibum, Imco
Hagedoorn, Paul
Botterman, Carel O.
Frijlink, Henderik W.
Grasmeijer, Floris
Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
title Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
title_full Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
title_fullStr Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
title_full_unstemmed Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
title_short Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
title_sort automated filling equipment allows increase in the maximum dose to be filled in the cyclops(®) high dose dry powder inhalation device while maintaining dispersibility
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407802/
https://www.ncbi.nlm.nih.gov/pubmed/32659899
http://dx.doi.org/10.3390/pharmaceutics12070645
work_keys_str_mv AT sibumimco automatedfillingequipmentallowsincreaseinthemaximumdosetobefilledinthecyclopshighdosedrypowderinhalationdevicewhilemaintainingdispersibility
AT hagedoornpaul automatedfillingequipmentallowsincreaseinthemaximumdosetobefilledinthecyclopshighdosedrypowderinhalationdevicewhilemaintainingdispersibility
AT bottermancarelo automatedfillingequipmentallowsincreaseinthemaximumdosetobefilledinthecyclopshighdosedrypowderinhalationdevicewhilemaintainingdispersibility
AT frijlinkhenderikw automatedfillingequipmentallowsincreaseinthemaximumdosetobefilledinthecyclopshighdosedrypowderinhalationdevicewhilemaintainingdispersibility
AT grasmeijerfloris automatedfillingequipmentallowsincreaseinthemaximumdosetobefilledinthecyclopshighdosedrypowderinhalationdevicewhilemaintainingdispersibility